ChemicalBook >> CAS DataBase List >>Peptide T TFA

Peptide T TFA

CAS No.
1610056-01-3
Chemical Name:
Peptide T TFA
Synonyms
Peptide T TFA;((2S)-2-((2S,3R)-2-((2S,3R)-2-((S)-2-((S)-2-aminopropanamido)-3-hydroxypropanamido)-3-hydroxybutanamido)-3-hydroxybutanamido)-3-hydroxybutanoyl)-L-asparaginyl-L-tyrosyl-L-threonine compound with 2,2,2-trifluoroacetic acid (1:1)
CBNumber:
CB24713793
Molecular Formula:
C37H56F3N9O18
Molecular Weight:
971.9
MDL Number:
MFCD31692429
MOL File:
1610056-01-3.mol
Last updated:2025-06-18 16:39:23
Product description Number Pack Size Price
PeptideTTFA CS-0058419 1mg $100
PeptideTTFA CS-0058419 5mg $220
PeptideTTFA CS-0058419 10mg $380

Peptide T TFA Properties

storage temp. Store at -20°C
solubility Soluble in DMSO
Sequence Ala-Ser-Thr-Thr-Thr-Asn-Tyr-Thr

Peptide T TFA price

Manufacturer Product number Product description CAS number Packaging Price Updated Buy
ChemScene CS-0058419 PeptideTTFA 1610056-01-3 1mg $100 2021-12-16 Buy
ChemScene CS-0058419 PeptideTTFA 1610056-01-3 5mg $220 2021-12-16 Buy
ChemScene CS-0058419 PeptideTTFA 1610056-01-3 10mg $380 2021-12-16 Buy
Product number Packaging Price Buy
CS-0058419 1mg $100 Buy
CS-0058419 5mg $220 Buy
CS-0058419 10mg $380 Buy

Peptide T TFA Chemical Properties,Uses,Production

Uses

Peptide T (TFA) is an octapeptide from the V2 region of HIV-1 gp120. Peptide T is a ligand for the CD4 receptor and prevents binding of HIV to the CD4 receptor.

in vivo

Peptide T is administered subcutaneously at different doses and phases of the experimental autoimmune encephalomyelitis (EAE) disease, but Peptide T neither prevents nor ameliorates EAE[4].

IC 50

HIV-1

References

[1] Ruff MR, et al. Peptide T[4-8] is core HIV envelope sequence required for CD4 receptor attachment. Lancet. 1987 Sep 26;2(8561):751. DOI:10.1016/s0140-6736(87)91120-2
[2] Ruff MR, et al. Peptide T inhibits HIV-1 infection mediated by the chemokine receptor-5 (CCR5). Antiviral Res. 2001 Oct;52(1):63-75. DOI:10.1016/s0166-3542(01)00163-2
[3] Raychaudhuri SP, et al. Immunomodulatory effects of peptide T on Th 1/Th 2 cytokines. Int J Immunopharmacol. 1999 Sep;21(9):609-15. DOI:10.1016/s0192-0561(99)00041-7
[4] Sáez-Torres I, et al. Peptide T does not ameliorate experimental autoimmune encephalomyelitis (EAE) in Lewis rats. Clin Exp Immunol. 2000 Jul;121(1):151-6. DOI:10.1046/j.1365-2249.2000.01259.x

Peptide T TFA Preparation Products And Raw materials

Raw materials

Preparation Products

Peptide T TFA Suppliers

Global( 8)Suppliers
Supplier Tel Email Country ProdList Advantage
BOC Sciences
16314854226; +16314854226 inquiry@bocsci.com United States 19654 58
Creative Peptides info@creative-peptides.com United States 6083 56
ChemeGen(Shanghai) Biotechnology Co.,Ltd. 18818260767 sales@chemegen.com China 11218 58
Birdo (Shanghai) Medical Technology Co., Ltd. 021-58099077-8041 18601625411 sales@birdotech.com China 9763 58
Taizhou Nanfeng Pharmaceutical Research Institute nanfengdrug@163.com; 18616377689 nanfengdrug@163.com China 20009 58
Ontores Biotech 0571-88760729 18072970094 supports@ontorespeptide.com China 2696 58
Peptide T TFA ((2S)-2-((2S,3R)-2-((2S,3R)-2-((S)-2-((S)-2-aminopropanamido)-3-hydroxypropanamido)-3-hydroxybutanamido)-3-hydroxybutanamido)-3-hydroxybutanoyl)-L-asparaginyl-L-tyrosyl-L-threonine compound with 2,2,2-trifluoroacetic acid (1:1) 1610056-01-3